BTSG BrightSpring Health Services, Inc.

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business: Integrated home and community-based healthcare platform delivering complementary pharmacy and provider services to complex Senior and Specialty patients
• • Strategic shift: Divestiture of Community Living business for $835M, focusing on streamlined Provider Services like home health, hospice, rehab, and primary care
• • New emphasis: Expanded home-based primary care and value-based care contracts leveraging integrated pharmacy-provider model to improve outcomes and reduce costs
• • Scale and reach: Serving over 465,000 patients daily via ~10,500 clinical providers and pharmacists across all 50 states, with 43M prescriptions filled in 2025
• • Noteworthy metric: Infusion and specialty pharmacy prescriptions grew 27%, home and community pharmacy 3% from 2024 to 2025, with 99.99% order accuracy and 99.34% completeness

Risk Factors

• • Medicare Home Health Prospective Payment System changes, including PDGM implemented 2020, affecting reimbursement based on patient mix and admission source
• • Exposure to Medicaid Integrity Program audits in six states, causing administrative costs and payment delays through 2029 under Review Choice Demonstration
• • Supplier relationship risk in Pharmacy Solutions, including loss of access to limited distribution pharmaceuticals impacting competitive positioning
• • Competition from vertically integrated rivals with exclusive pharmaceutical supply contracts and retail pharmacy chains limiting price competitiveness
• • Managed care contract risk with payors able to terminate contracts on 60-day notice, creating leverage to reduce volume or pricing favorable to payors

Management Discussion & Analysis

• • Consolidated revenue $12.91B in 2025, up 27.7% YoY from $10.12B in 2024; Pharmacy Solutions best performing segment, up 30.7% to $11.45B; Provider Services up 11.1% to $1.46B
• • Operating margin Pharmacy Solutions 3.8% vs 3.2%; Provider Services operating margin 14.0% vs 13.7%; consolidated EBITDA $776.2M, up 33.7% from $580.0M
• • Pharmacy Solutions segment EBITDA $543.5M, up 37.7%; Provider Services segment EBITDA $232.7M, up 13.3%; Pharmacy Solutions margin lower due to product mix shift
• • Net cash provided by operating activities $490.2M vs $23.8M; investing cash used $305.1M vs $140.2M (includes $144.8M acquisition spend); financing cash used $157.9M primarily debt repayment and $43.2M share repurchases
• • Management expects existing liquidity including $565.6M cash and revolving credit availability sufficient for next 12 months; key risks include integration costs, specialty drug mix shift affecting margins

What are the latest BTSG SEC filings in 2026?

BrightSpring Health Services, Inc. (BTSG) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on May 1, 2026, an 8-K current report on July 31, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did BTSG file its most recent 10-K annual report?

BrightSpring Health Services, Inc. (BTSG) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view BTSG 10-Q quarterly reports?

BrightSpring Health Services, Inc. (BTSG)'s most recent 10-Q quarterly report was filed on May 1, 2026. SignalX displays every BTSG 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has BTSG filed recently?

BrightSpring Health Services, Inc. (BTSG)'s most recent 8-K was filed on July 31, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find BTSG insider trading activity (Form 4)?

SignalX aggregates every BTSG Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does BTSG file with the SEC?

BrightSpring Health Services, Inc. (BTSG) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new BTSG filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for BrightSpring Health Services, Inc. (BTSG).

What is BTSG's SEC CIK number?

BrightSpring Health Services, Inc. (BTSG)'s SEC CIK (Central Index Key) number is 1865782. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1865782 to look up all BTSG filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find BTSG return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from BrightSpring Health Services, Inc. (BTSG) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.